Stable Istotope Labelled Pritoxaximab Biosimilar – Anti-shiga toxin type 1 B subunit mAb – Research Grade
Size | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Stable Istotope Labelled Pritoxaximab Biosimilar - Anti-shiga toxin type 1 B subunit mAb - Research Grade |
---|---|
Source | CAS 1351470-16-0 |
Species | Chimeric |
Expression system | Mammalian cells |
Purity | >95% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue Ice |
Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Aliases /Synonyms | Shigamabs-(drug name for the combination of pritoxaximab and setoxaximab),caStx1 |
Reference | PX-TA1318-SIL |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG1-kappa |
Clonality | Monoclonal Antibody |
Format | Lyophilized |
Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
Isotopic Enrichment | 99% |
Stability | 1 year |
General information on Anti-shiga toxin type 1 B subunit[Escherichia coli] (Pritoxaximab) Monoclonal Antibody
Pritoxaximab has been investigated for the prevention and treatment of Shiga-like toxin-producing Escherichia coli(STEC) or E. coli serotype O121 infection.
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.